PTGER2 and invasive breast carcinoma: It has been reported that COX2 expression in tumor epithelial cells was stimulated in response to inflammatory or stromal fibroblasts during the progression of ductal carcinoma in situ (DCIS) to invasive breast carcinomas in a tumor xenograft model [11].